<DOC>
	<DOCNO>NCT01973231</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate efficacy safety liraglutide versus lixisenatide add-on metformin subject type 2 diabetes ( T2DM ) .</brief_summary>
	<brief_title>Efficacy Safety Liraglutide Versus Lixisenatide add-on Metformin Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . Trialrelated activity procedure carry part trial , include activity determine suitability trial Subjects diagnose T2DM unchanged metformin treatment maximum tolerate dose ( least 1000 mg/day 3000 mg/day ) least 90 day prior screen HbA1c 7.5 10.5 % ( 53 mmol/mol 91 mmol/mol ) ( inclusive ) Body Mass Index ( BMI ) equal 20 kg/m^2 Female childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method . ( Adequate contraceptive measure require local law practice ) Treatment glucose lower agent ( ) state inclusion criterion period 90 day prior screen . Exception shortterm treatment ( equal 7 day total ) insulin connection intercurrent illness History chronic pancreatitis idiopathic acute pancreatitis Screening calcitonin value equal 50 ng/L Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia syndrome type 2 ( MEN 2 ) Impaired liver function , define alanine aminotransferase ( ALAT ) equal 2.5 time upper normal limit ( UNL ) Impaired renal function define estimate glomerular filtration rate ( eGFR ) 60 mL/min/1.73 m^2 per Modification Diet Renal Disease ( MDRD ) formula Any episode unstable angina , acute coronary event , cerebral stroke/transient ischemic attack ( TIA ) significant cardiovascular event judge investigator within 90 day prior screen Heart failure , New York Heart Association ( NYHA ) class IV Uncontrolled hypertension ( define systolic blood pressure equal 180 mmHg and/or diastolic blood pressure equal 100 mmHg ) Diagnosis malignant neoplasm previous 5 year ( except basal cell skin cancer squamous cell skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>